Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatic Encephalopathy Stage 2”

10 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 10 results

Post-approval studies (Phase 4)UnknownNCT05920213
What this trial is testing

Efficacy of L-Ornithine L-Aspartate and Polyethylene Glycol in Cirrhotic Patients With Overt Hepatic Encephalopathy

Who this might be right for
Hepatic Encephalopathy Stage 2Hepatic Encephalopathy Stage 3Hepatic Encephalopathy Stage 4
Jinnah Postgraduate Medical Centre 360
Testing effectiveness (Phase 2)Study completedNCT00867698
What this trial is testing

AST-120 Used to Treat Mild Hepatic Encephalopathy

Who this might be right for
Mild Hepatic Encephalopathy
Ocera Therapeutics 148
Testing effectiveness (Phase 2)Looking for participantsNCT06823713
What this trial is testing

RTX001 Autologous Engineered Macrophages for Liver Cirrhosis

Who this might be right for
End-stage Liver Disease (ESLD)Cirrhosis, LiverCirrhosis, Decompensated+5 more
Resolution Therapeutics Limited 30
Testing effectiveness (Phase 2)Ended earlyNCT06987968
What this trial is testing

See if an Investigational Medicine Called VS-01 Can Help and How Safe it is in the Treatment of Patients With Overt Hepatic Encephalopathy

Who this might be right for
Hepatic EncephalopathyAcute on Chronic Liver Failure (ACLF)Decompensated Cirrhosis
Genfit 3
Testing effectiveness (Phase 2)Study completedNCT00558038
What this trial is testing

Safety and Efficacy of AST-120 Compared to Lactulose in Patients With Hepatic Encephalopathy

Who this might be right for
Hepatic Encephalopathy
Ocera Therapeutics 40
Testing effectiveness (Phase 2)Ended earlyNCT04816916
What this trial is testing

Efficacy and Safety of AXA1665 in Cirrhotic Subjects With Prior Overt Hepatic Encephalopathy

Who this might be right for
Hepatic Encephalopathy
Axcella Health, Inc 12
Testing effectiveness (Phase 2)Study completedNCT00999167
What this trial is testing

Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy

Who this might be right for
CirrhosisHepatic Encephalopathy
Amgen 189
Testing effectiveness (Phase 2)Ended earlyNCT00597909
What this trial is testing

Efficacy and Safety Study of Ammonul® in Patients With Grade 3 or 4 Hepatic Encephalopathy

Who this might be right for
Hepatic Encephalopathy
Amgen 1
Not applicableStudy completedNCT04787276
What this trial is testing

Efficacy and Safety of E.Coli Nissle 1917 in Patients With Mild (Stage 1-2) or Minimal Hepatic Encephalopathy

Who this might be right for
Hepatic EncephalopathyLiver CirrhosisEnd Stage Liver DIsease
Bogomolets National Medical University 42
Not applicableActive Not RecruitingNCT04315571
What this trial is testing

Comparing Ascites Relief In Two Standard Treatments: Large Volume Paracentesis Vs. Early Tips Using Viatorr Controlled Expansion Stents

Who this might be right for
Hypertension, PortalAscites
University of California, Los Angeles 68